Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Halaven in pretreated metastatic breast cancer
NCT01908101Phase 2Completed
- Sponsor
- University of Washington
- Start
- Jan 2014
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eribulin in breast cancer, sponsored by University of Washington. Started Jan 2014; status: completed.
02
Drugs
eribulin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01908101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01908101.